CMS to add star ratings to health plans

CMS is planning to add a star ratings system to insurance plans offered through the individual exchange created from the Affordable Care Act, the agency announced August 15. The new ratings will be displayed for the 2020 open enrollment period on Healthcare.gov.

According to CMS, the change will help consumers make more informed decisions about their healthcare coverage, develop more oversight of health plans and give actionable information to health plans on how to improve the quality of services they provide.

“Knowledge is power, and for the first time, consumers will have access to meaningful, simple-to-use information to compare the quality, along with the price, of health plans on Exchange websites, including HealthCare.gov,” CMS Administrator Seema Verma said in a statement. “This addresses our strongly held commitment to equip consumers with the tools they need to find the best choice possible. Increasing transparency and competition drive better quality and cost, with consumers benefitting the most.”

Under the new plan, health plans will be given a star rating out of five stars, with five stars representing the highest quality. Plans will be rated across three categories, including member experience, medical care and plan administration, which will each have their own five-star rating scale.

In total, the quality rating system includes 38 quality measures, with 28 clinical quality measures focused on the quality of healthcare services provided and 10 survey measures from enrollees’ experience with their health plan. Consumers will see the star ratings on open enrollment or a notice if the plan hasn’t been rated.

The star ratings system for individual health plans follows a limited pilot program from CMS to add the ratings to some health plans in the 2017 and 2018 open enrollment periods. Healthcare providers that offer care under Medicare and Medicaid already are rated through a star rating system that gives patients more information.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The company has agreed to acquire Verve Therapeutics for an upfront payment of approximately $1 billion. The total could increase significantly, however, if certain milestones are met. One of Verve's biggest gene therapies has already received the FDA's fast track designation.

American College of Cardiology Board of Governors Chair David E. Winchester, MD, MS, examines the many benefits of working with the American Medical Association House of Delegates to bring about significant change.

“Without a more concrete and stable policy on these tariffs from the current American administration, it is likely that most manufacturers will be forced to continuously change their internal forecasts and production plans," one analyst said.